80680-43-9 (D-肌醇,5-O-b-D-吡喃木糖基-,4-[(6S,7R,8S,8aR)-6'-溴-1,1',2',3,4,6,8,8a,9,10-十氢-6-羟基-6-甲基-2,2',4-三氧螺[e]嘧啶[4,5-b][1,4]二氮杂卓-7(2H),3'-[3H]吲哚]-8-羧酸酯](9CI),D-myo-Inositol, 5-O-b-D-xylopyranosyl-,4-[(6S,7R,8S,8aR)-6'-bromo-1,1',2',3,4,6,8,8a,9,10-decahydro-6-hydroxy-6-methyl-2,2',4-trioxospiro[cyclopenta[e]pyrimido[4,5-b][1,4]diazepine-7(2H),3'-[3H]indole]-8-carboxylate](9CI))

CAS号:
80680-43-9
中文名称:
D-肌醇,5-O-b-D-吡喃木糖基-,4-[(6S,7R,8S,8aR)-6'-溴-1,1',2',3,4,6,8,8a,9,10-十氢-6-羟基-6-甲基-2,2',4-三氧螺[e]嘧啶[4,5-b][1,4]二氮杂卓-7(2H),3'-[3H]吲哚]-8-羧酸酯](9CI)
英文名称:
D-myo-Inositol, 5-O-b-D-xylopyranosyl-,4-[(6S,7R,8S,8aR)-6'-bromo-1,1',2',3,4,6,8,8a,9,10-decahydro-6-hydroxy-6-methyl-2,2',4-trioxospiro[cyclopenta[e]pyrimido[4,5-b][1,4]diazepine-7(2H),3'-[3H]indole]-8-carboxylate](9CI)
分子式:
C30H34BrN5O15
分子量:
784.519467830658

D-肌醇,5-O-b-D-吡喃木糖基-,4-[(6S,7R,8S,8aR)-6'-溴-1,1',2',3,4,6,8,8a,9,10-十氢-6-羟基-6-甲基-2,2',4-三氧螺[e]嘧啶[4,5-b][1,4]二氮杂卓-7(2H),3'-[3H]吲哚]-8-羧酸酯](9CI)(80680-43-9)名称与标识符

名称

英文别名:
D-myo-Inositol, 5-O-b-D-xylopyranosyl-,4-[(6S,7R,8S,8aR)-6'-bromo-1,1',2',3,4,6,8,8a,9,10-decahydro-6-hydroxy-6-methyl-2,2',4-trioxospiro[cyclopenta[e]pyrimido[4,5-b][1,4]diazepine-7(2H),3'-[3H]indole]-8-carboxylate](9CI);D-myo-Inositol, 5-O-b-D-xylopyranosyl-,4-[(6S,7R,8S,8aR)-6'-bromo-1,1',2',3,4,6,8,8a,9,10-decahydro-6-hydroxy-6-methyl-2,2',4-trioxospiro[cyclopenta[e]pyrimido[4,5-b][1,4]diazepine-7(2H),3'-[3H]indole;Neosurugatoxin;D-myo-Inositol, 5-O-beta-D-xylopyranosyl-, 4-(6'-bromo-1,1',2',3,4,6,8,8a,9,10-decahydro-6-hydroxy-6-methyl-2,2',4-trioxospiro(cyclopenta(e)pyrimido(4,5-b)(1,4)diazepine-7(2H),3'-(3H)indole)-8-carboxylate), (6S-(6alpha,7alpha,8alpha,8aalpha))-;DTXSID801001409;80680-43-9;[(2S,3S,4R,5S)-2,3,4,5-Tetrahydroxy-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxycyclohexyl] (3R,4'S,6'S,7'R)-6-bromo-4'-hydroxy-4'-methyl-2,12',14'-trioxospiro[1H-indole-3,5'-2,9,11,13-tetrazatricyclo[8.4.0.03,7]tetradeca-1(10),2-diene]-6'-carboxylate;2,3,4,5-Tetrahydroxy-6-(pentopyranosyloxy)cyclohexyl 6'-bromo-2,2',4,6-tetrahydroxy-6-methyl-8,8a,9,10-tetrahydro-6H-spiro[cyclopenta[e]pyrimido[4,5-b][1,4]diazepine-7,3'-indole]-8-carboxylate;D-myo-Inositol, 5-O-beta-D-xylopyranosyl-, 4-((6S,7R,8S,8aR)-6'-bromo-1,1',2',3,4,6,8,8a,9,10-decahydro-6-hydroxy-6-methyl-2,2',4-trioxospiro(cyclopenta(e)pyrimido(4,5-b)(1,4)diazepine-7(2H),3'-(3H)indole)-8-carboxylate);Q27149744;CHEBI:80710;

标识符

InChIKey:
BQGIDCZWFREXJV-IFKJOSTCSA-N
Inchi:
1S/C30H34BrN5O15/c1-29(48)22-8(5-32-23-13(34-22)24(44)36-28(47)35-23)12(30(29)9-3-2-7(31)4-10(9)33-27(30)46)25(45)50-20-17(41)15(39)16(40)18(42)21(20)51-26-19(43)14(38)11(37)6-49-26/h2-4,8,11-12,14-21,26,37-43,48H,5-6H2,1H3,(H,33,46)(H3,32,35,36,44,47)/t8-,11+,12+,14-,15-,16+,17-,18-,19+,20?,21?,26-,29+,30+/m0/s1
SMILES:
BrC1C=CC2=C(C=1)NC([C@]12[C@@](C)(C2[C@@H](CNC3=C(C(NC(N3)=O)=O)N=2)[C@@H]1C(=O)OC1[C@H]([C@H]([C@H]([C@@H](C1O[C@H]1[C@@H]([C@H]([C@@H](CO1)O)O)O)O)O)O)O)O)=O

D-肌醇,5-O-b-D-吡喃木糖基-,4-[(6S,7R,8S,8aR)-6'-溴-1,1',2',3,4,6,8,8a,9,10-十氢-6-羟基-6-甲基-2,2',4-三氧螺[e]嘧啶[4,5-b][1,4]二氮杂卓-7(2H),3'-[3H]吲哚]-8-羧酸酯](9CI)(80680-43-9)物化性质

计算特性

  • 精确分子量 : 783.12348g/mol
  • 氢键供体数量 : 12
  • 氢键受体数量 : 17
  • 可旋转化学键数量 : 5
  • 同位素质量 : 783.12348g/mol
  • 重原子数量 : 51
  • 复杂度 : 1570
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 12
  • 不确定原子立构中心数量 : 2
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : -5.6
  • 拓扑分子极性表面积 : 318Ų